This study from MSK compared salvage low dose rate brachytherapy (seeds) to high dose rate brachytherapy (temporary implants) as treatments after failure of primary radiotherapy. They were equally effective (about
60% by 3 years) and had equally low rates of toxicity. I'm sure their effectiveness will go up considerably with better patient selection using the new generation of PET scans:
/pcnrv.blogspot.com/2017/08/after-failure-of-first-line-radiation.htmlAlso, NIH will soon start recruitment for a salvage SBRT clinical trial. The clinical trial in San Diego (Don Fuller) has reported a 2-year recurrence-free survival of 82%, so those of you who can't travel to San Diego for that might sign up. They are also screening with the DCFPyL PET scan, which is the best of the new generation. Because it's NIH, it is free and they cover travel and accommodations to D.C. Here's the contact info:
/clinicaltrials.gov/ct2/show/NCT03253744